ACAT1
Acetyl-CoA acetyltransferase, mitochondrial
Also known as: ACAT, THIL, THIL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P24752
- Gene
- ACAT1
- Ensembl
- ENSG00000075239
- Chromosome
- 11
- Canonical length
- 427 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a mitochondrially localized enzyme that catalyzes the reversible formation of acetoacetyl-CoA from two molecules of acetyl-CoA. Defects in this gene are associated with 3-ketothiolase deficiency, an inborn error of isoleucine catabolism characterized by urinary excretion of 2-methyl-3-hydroxybutyric acid, 2-methylacetoacetic acid, tiglylglycine, and butanone. [provided by RefSeq, Feb 2009]
Canonical amino-acid sequenceUniProt
427 residues, UniProt reviewed canonical sequence.
>P24752|ACAT1
1 MAVLAALLRS GARSRSPLLR RLVQEIRYVE RSYVSKPTLK EVVIVSATRT PIGSFLGSLS
61 LLPATKLGSI AIQGAIEKAG IPKEEVKEAY MGNVLQGGEG QAPTRQAVLG AGLPISTPCT
121 TINKVCASGM KAIMMASQSL MCGHQDVMVA GGMESMSNVP YVMNRGSTPY GGVKLEDLIV
181 KDGLTDVYNK IHMGSCAENT AKKLNIARNE QDAYAINSYT RSKAAWEAGK FGNEVIPVTV
241 TVKGQPDVVV KEDEEYKRVD FSKVPKLKTV FQKENGTVTA ANASTLNDGA AALVLMTADA
301 AKRLNVTPLA RIVAFADAAV EPIDFPIAPV YAASMVLKDV GLKKEDIAMW EVNEAFSLVV
361 LANIKMLEID PQKVNINGGA VSLGHPIGMS GARIVGHLTH ALKQGEYGLA SICNGGGGAS
421 AMLIQKLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACAT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 906 nTPM
Expression across tissuesHPA
Tissue
- liver: 906 nTPM
- kidney: 581 nTPM
- skeletal muscle: 435 nTPM
- tongue: 384 nTPM
- heart muscle: 299 nTPM
- choroid plexus: 275 nTPM
Single-cell type
- hepatocytes: 805 nCPM
- parietal cells: 484 nCPM
- early spermatids: 444 nCPM
- late primary spermatocytes: 404 nCPM
- myonuclei: 275 nCPM
- epididymal clear cells: 263 nCPM
Immune cell
- T-reg: 36 nTPM
- myeloid DC: 34 nTPM
- MAIT T-cell: 30 nTPM
- memory CD8 T-cell: 30 nTPM
- memory B-cell: 29 nTPM
- memory CD4 T-cell: 29 nTPM
Brain region
- choroid plexus: 124 nTPM
- cerebellum: 29 nTPM
- white matter: 29 nTPM
- spinal cord: 29 nTPM
- hypothalamus: 28 nTPM
- thalamus: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACAT1.
Disease | AllUniProt
Conditions ACAT1 is implicated in, by any mechanism.
- 3-ketothiolase deficiency (3KTD) MIM:203750
Disease | GeneticClinVar
213 pathogenic / likely-pathogenic of 808 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Deficiency of acetyl-CoA acetyltransferase
- ACAT1-related disorder
- Inborn genetic diseases
- Sarcoma
- Nonpapillary renal cell carcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.05
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.91
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acetyl-CoA biosynthetic process
- acetyl-CoA catabolic process
- adipose tissue development
- coenzyme A biosynthetic process
- coenzyme A metabolic process
- fatty acid beta-oxidation
- ketone body catabolic process
- ketone body metabolic process
- L-isoleucine catabolic process
- liver development
- response to hormone
- response to starvation
- metanephric proximal convoluted tubule development
- propionyl-CoA biosynthetic process
Molecular functions
- acetyl-CoA C-acetyltransferase activity
- cholesterol O-acyltransferase activity
- coenzyme A binding
- enzyme binding
- identical protein binding
- potassium ion binding
- C-acetyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACAT1 as an antibody target. Whether an autoantibody or antibody against ACAT1 could matter depends on whether native ACAT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACAT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACAT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...